Business Wire (May 13, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
173 people get PVCT.OB articles and Market Currents by email alert.
Get email alerts on PVCT.OB »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Apr 10, 2013)
-
Business Wire (Mar 21, 2013)
-
Business Wire (Oct 29, 2012)
-
Business Wire (Oct 17, 2012)
-
Business Wire (Oct 2, 2012)
-
Business Wire (Sep 27, 2012)
-
Business Wire (Sep 19, 2012)
-
Business Wire (Jul 17, 2012)
-
Business Wire (May 30, 2012)
-
-
Business Wire (May 14, 2012)
To learn more about Seeking Alpha Pro, click here.
-
Provectus Gains Momentum Ahead of Upcoming Melanoma Data PresentationM. E. Garza • Wed, Oct 27, 2010 -
Provectus Granted Patents for Cancer Imaging DrugChinaBio Today • Wed, Feb 27, 2008 -
Tiny Provectus Pharmaceuticals Jumps 15% on 6x VolumeH.S. Ayoub • Tue, Apr 24, 2007
-
Business Wire (May 13, 2013)
-
Business Wire (Apr 10, 2013)
-
Business Wire (Mar 21, 2013)
-
Business Wire (Oct 29, 2012)
-
Business Wire (Oct 17, 2012)
-
Business Wire (Oct 2, 2012)
-
Business Wire (Sep 27, 2012)
-
Business Wire (Sep 19, 2012)
-
Business Wire (Jul 17, 2012)
-
Business Wire (May 30, 2012)
-
Business Wire (May 14, 2012)
PVCT.OB vs. ETF Alternatives
Company Description
Currently, there's no company description for PVCT.OB.
-
World Market Media
Provectus Pharmaceuticals (OTC:PVCT.OB) to Present Phase 2 Results http://bit.ly/a0107a - View all 0 replies
-
World Market Media
WMM Midday Micro and Nano Cap Movers (AMEX: FOH) (NASDAQ: KONA, CYCC, PXLW) (OTCBB: PVCT.OB) http://bit.ly/9gRdn5 - View all 0 replies
-
World Market Media
Provectus Pharmaceuticals (OTCBB: PVCT.OB) $103M (MarketCap) Reports Positive Data on Visceral Metastases http://bit.ly/9zkAnL - View all 0 replies
-
- View all 0 replies
LATEST REPLIES